Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to evaluate the safety and efficacy of the combination therapy with Transcatheter Arterial Chemoembolization (TACE) and sorafenib compared to TACE alone in patients with unresectable hepatocellular carcinoma (HCC) who are not candidates for surgical resection or percutaneous ablation therapy.
Epistemonikos ID: 5c82815b2e6de9508b2a6354a89b450dc63541b1
First added on: May 06, 2024